Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database.
Saved in:
| Title: | Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database. |
|---|---|
| Authors: | Zhang H; Department of Obstetrics and Gynecology, Northwest University First Hospital, Xi'an, Shaanxi, China., Zhou Z; Department of Obstetrics and Gynecology, Northwest University First Hospital, Xi'an, Shaanxi, China., Wang J; Department of Obstetrics and Gynecology, Northwest University First Hospital, Xi'an, Shaanxi, China., Wang S; Department of Obstetrics and Gynecology, Northwest University First Hospital, Xi'an, Shaanxi, China., Ren J; Department of Obstetrics and Gynecology, Northwest University First Hospital, Xi'an, Shaanxi, China., Zhang M; Department of General Practice, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China., Yang M; Department of Joint Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Apr 08; Vol. 16, pp. 1582050. Date of Electronic Publication: 2025 Apr 08 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1582050 |
